Sally Hopewell

Statistics and Probability · 2007–2025

A researcher in the Science corpus: 12 papers; trusts 7 researchers and is trusted by 6 researchers here, as inferred from the citation graph.

Subfields

• Statistics and Probability — 141 citations into it; #5,406 of 12,932 by trust here, #518 by citations
• Economics and Econometrics — 95 citations into it; #13,007 of 23,481 by trust here, #2,888 by citations
• Public Health, Environmental and Occupational Health — 49 citations into it; #673 of 2,368 by trust here, #205 by citations
• General Health Professions — 37 citations into it

Whom Sally Hopewell trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. Douglas G. Altman
2. David Moher
3. K. F. Schulz
4. Sander Greenland
5. Peter Jüni
6. Diana Elbourne
7. Matthias Egger
8. Patrick M. M. Bossuyt
9. A. Chan
10. G. Piaggio

Who trusts Sally Hopewell overall

1. Douglas G. Altman
2. David Moher
3. Julian P. T. Higgins
4. K. F. Schulz
5. J. Gagnier
6. Bryan G. Cook
7. Gunther Eysenbach
8. G. Kienle
9. W. Lin
10. Emily M. Bender

Papers from Sally Hopewell's perspective

Ordered by how strongly the researchers Sally Hopewell trusts endorse each paper. Same corpus, a different order for every researcher.

1. CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials (British medical journal)
2. Principles of multilevel modelling. (International Journal of Epidemiology)
3. What is missing from descriptions of treatment in trials and reviews? (British medical journal)
4. Optimal medical therapy with or without PCI for stable coronary disease. (New England Journal of Medicine)
5. Vasopressin versus norepinephrine infusion in patients with septic shock. (New England Journal of Medicine)
6. Comparison of Weight-Loss Diets with Different Compositions of Fat, Protein, and Carbohydrates (New England Journal of Medicine)
7. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. (The Lancet)
8. Statistical considerations in the intent-to-treat principle. (Controlled Clinical Trials)
9. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. (New England Journal of Medicine)
10. Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study. (The Lancet)

Their papers

• CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials (2010) — 6,841 citations
• CONSORT for Reporting Randomized Controlled Trials in Journal and Conference Abstracts: Explanation and Elaboration (2008) — 615 citations
• CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. (2012) — 3,604 citations
• RoB 2: a revised tool for assessing risk of bias in randomised trials (2019) — 28,662 citations
• PRISMA for Abstracts: Reporting Systematic Reviews in Journal and Conference Abstracts (2013) — 611 citations
• Grey literature in meta-analyses of randomized trials of health care interventions. (2007) — 614 citations
• Publication bias in clinical trials due to statistical significance or direction of trial results. (2009) — 875 citations
• Defining Feasibility and Pilot Studies in Preparation for Randomised Controlled Trials: Development of a Conceptual Framework (2016) — 1,273 citations
• CONSORT 2025 statement: updated guideline for reporting randomised trials (2025) — 646 citations
• CONSORT 2025 statement: updated guideline for reporting randomised trials. (2025) — 743 citations
• Exercise for preventing falls in older people living in the community. (2016) — 1,176 citations
• Atrial fibrillation and risks of cardiovascular disease, renal disease, and death: systematic review and meta-analysis (2016) — 800 citations